Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-015-3653-3
Published Online: 2015-12-07
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kolben, Thomas
Augustin, D.
Armbrust, R.
Kolben, T. M.
Degenhardt, T.
Burgmann, M.
Goess, C.
Ditsch, N.
Kates, R.
Harbeck, N.
Wuerstlein, R.
Text and Data Mining valid from 2015-12-07